FindMyKOL
Clinical trialNCT04854005Active, not recruitingObservational

Use of Sentinel Lymph Node Biopsy in Patients With Early-Stage, Palpable Node-Positive HR+/HER2- Breast Cancer Having Upfront Surgery and Adjuvant Radiation

SponsorMemorial Sloan Kettering Cancer CenterEnrollment78Breast Cancer
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to find out how often the researchers can avoid an ALND in patients with early-stage, node-positive HR+/HER2- breast cancer who are having upfront surgery. The study researchers think that, if AUS before surgery can help identify people who may have up to 3 affected lymph nodes, it will be possible to perform the less radical standard SLNB during surgery.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Hartford Healthcare Cancer Alliance (data Collection Only)

    Hartford, Connecticut, United States

  • University of Michigan (data Collection Only)

    Ann Arbor, Michigan, United States

  • Memorial Sloan Kettering Basking Ridge (consent Only)

    Basking Ridge, New Jersey, United States

  • Memorial Sloan Kettering Monmouth (all Protocol Activities)

    Middletown, New Jersey, United States

  • Memorial Sloan Kettering Bergen (consent Only)

    Montvale, New Jersey, United States

  • Memorial Sloan Kettering Suffolk - Commack (consent Only)

    Commack, New York, United States

  • Memorial Sloan Kettering Westchester (consent Only)

    Harrison, New York, United States

  • Memorial Sloan Kettering Cancer Center

    New York, New York, United States

  • Memorial Sloan Kettering Nassau (consent Only)

    Uniondale, New York, United States

  • Lehigh Valley Health Network (dara Collection Only)

    Allentown, Pennsylvania, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
20 May 2021
Primary completion
30 Apr 2027
Completion
30 Apr 2027
Last update posted
3 Aug 2026
Registered enrollment
78
Registry id
NCT04854005
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.